Empfield James R.

Empfield James R. is listed in filings as EVP at Xenon Pharmaceuticals Inc.. This profile follows SEC Form 4 activity through Mar 12, 2024, including 1 public disclosure. Recent filings connect the profile to Xenon Pharmaceuticals Inc. (XENE). The current snapshot covers public activity from Mar 12, 2024. Reported amounts are shown as $2.9M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.